Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
March 11, 2025
Advocate for Desmoid Tumor Research in Congress
Read More about Advocate for Desmoid Tumor Research in Congress
February 12, 2025
Recap: February Patient Education Event in Partnership with Penn Medicine
Read More about Recap: February Patient Education Event in Partnership with Penn Medicine
February 5, 2025
Note to DTRF Patient Registry Participants re: Migration to New Platform
Read More about Note to DTRF Patient Registry Participants re: Migration to New Platform
December 10, 2024
Update: OGSIVEO® (nirogacestat) Now Available in 150 mg and 100 mg Tablets
Read More about Update: OGSIVEO® (nirogacestat) Now Available in 150 mg and 100 mg Tablets
